Results 241 to 250 of about 190,151,534 (289)

Diminished Tyrosine Hydroxylase Immunoreactivity in the Cardiac Conduction System and Myocardium in Parkinson’s Disease: An Anatomical Study

Acta Neuropathologica, 2009
Clinical and autopsy studies have consistently reported cardiac sympathetic dysfunction in the left ventricular wall in patients with Parkinson's disease (PD). Whether the nerve fibers of the cardiac conduction system or the atrial walls are equally affected in this disease process has not yet been well documented.
Heiko Braak   +2 more
exaly   +6 more sources

Zebrafish Models in Therapeutic Research of Cardiac Conduction Disease

open access: yesFrontiers in Cell and Developmental Biology, 2021
Malfunction in the cardiac conduction system (CCS) due to congenital anomalies or diseases can cause cardiac conduction disease (CCD), which results in disturbances in cardiac rhythm, leading to syncope and even sudden cardiac death.
Rui Gao, Jie Ren
exaly   +3 more sources

Symptomatic Conduction System Disease in Cardiac Amyloidosis

The American Journal of Cardiology, 1997
Symptomatic conduction system disease in cardiac amyloidosis and its management has been reported infrequently. We report our experience of patients with amyloidosis having symptomatic conduction system disease requiring permanent pacemaker implantation.
V, Mathew   +3 more
openaire   +2 more sources

Specification of the Cardiac Conduction System by Transcription Factors

open access: yesCirculation Research, 2009
Diseases of the cardiovascular system that cause sudden cardiac deaths are often caused by lethal arrhythmias that originate from defects in the cardiac conduction system.
Craig T Basson
exaly   +1 more source

Can Cardiac Conduction System Disease Be Prevented?

JAMA Internal Medicine, 2016
Cardiac conduction system disorders on the electrocardiogram (ECG) are common. Left bundle branch block (LBBB) is associated with adverse outcomes, and variants previously considerednormal, suchas rightbundlebranchblock (RBBB),1 left anterior fascicularblock,2orPR intervalprolongation,3may also portend morbidity andmortality. At present, no paradigm to
Sanjiv M, Narayan   +2 more
openaire   +2 more sources

Hypertrophic Cardiomyopathy and Symptomatic Conduction System Disease in Cardiac Amyloidosis

Southern Medical Journal, 2006
Cardiac involvement is the most important prognostic factor in primary amyloidosis (AL). The clinical presentation of amyloid cardiomyopathy is varied and may manifest as heart failure, brady or tachyarrhythmias, syncope, angina and rarely with features of hypertrophic cardiomyopathy and advanced symptomatic conduction system disease. The management of
Praveen, Garg   +5 more
openaire   +2 more sources

Conduction System Disease in Fetuses Evaluated for Irregular Cardiac Rhythm

Fetal Diagnosis and Therapy, 2006
<i>Objectives:</i> To determine the prevalence of 1st and 2nd degree AV block in fetuses with an irregular cardiac rhythm, and to summarize outcome of these pregnancies. <i>Background:</i> The diagnosis of irregular cardiac rhythm or ‘skipped beats’ includes isolated ectopy that resolves spontaneously.
Bettina F, Cuneo   +3 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy